PUBLISHER: The Business Research Company | PRODUCT CODE: 1948602
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948602
Vaginal dilators are therapeutic medical tools designed to gently widen the vaginal canal. They come in different sizes and shapes and are used under medical guidance to address specific health conditions and improve comfort.
The primary types of vaginal dilators include silicone vaginal dilators, magnetic vaginal dilators, and others. Silicone vaginal dilators are medical devices manufactured from soft and flexible silicone material and are intended to assist in the gradual stretching of vaginal tissues. These products are distributed through channels such as online platforms, retail pharmacies, and others and are used in applications across hospitals, clinics, and other healthcare settings.
Tariffs have increased the cost of imported silicone, plastic, and magnetic components used in vaginal dilators, raising production and retail prices across the market. These impacts are most evident in silicone and magnetic dilator segments, particularly in Asia-Pacific and Europe where many raw materials and finished products are sourced internationally. Higher prices have affected affordability for clinics and home use consumers. However, tariffs have also encouraged local manufacturing and sourcing of medical grade materials, supporting regional production and improving long term supply stability.
The vaginal dilators market research report is one of a series of new reports from The Business Research Company that provides vaginal dilators market statistics, including vaginal dilators industry global market size, regional shares, competitors with a vaginal dilators market share, detailed vaginal dilators market segments, market trends and opportunities, and any further data you may need to thrive in the vaginal dilators industry. This vaginal dilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The vaginal dilators market size has grown strongly in recent years. It will grow from $25.21 billion in 2025 to $27.39 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of pelvic floor disorders, rising awareness of post-surgical therapy, technological improvements in medical-grade silicone devices, growth in gynecological clinics, expanding focus on women's sexual health.
The vaginal dilators market size is expected to see strong growth in the next few years. It will grow to $37.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to adoption of personalized and 3D-printed dilators, integration with mobile health apps, growth of telemedicine in gynecological care, increased demand for home-use therapy devices, rising awareness campaigns for pelvic floor rehabilitation. Major trends in the forecast period include 3d-printed customized dilators, ai-enabled therapy tracking, multi-size and multi-material devices, integration with telemedicine platforms, home-based pelvic floor therapy.
The growing prevalence of gynecological conditions is increasingly supporting the expansion of the vaginal dilators market going forward. Gynecological conditions refer to disorders, diseases, or medical issues affecting the female reproductive system. The prevalence of gynecological conditions is rising due to factors such as lifestyle changes, delayed childbearing, increased exposure to environmental toxins, and higher infection rates. Vaginal dilators serve as effective tools in managing gynecological conditions by helping reduce symptoms, support treatment outcomes, and improve overall quality of life for patients. For example, in October 2025, according to Cancer Australia, an Australia-based government agency, approximately 6,963 new cases of gynecological cancers were diagnosed in 2024, with estimates indicating that one in 23 women faces a lifetime risk of being diagnosed with a gynecological cancer by age 85. Consequently, the rising prevalence of gynecological conditions is contributing to growth in the vaginal dilators market.
Leading companies operating in the vaginal dilators market are focusing on innovative virtual clinical trials to evaluate device effectiveness, patient comfort, and long-term outcomes. Virtual clinical trials use decentralized, digital technologies to conduct research remotely. For example, in June 2024, Materna Medical Inc., a US-based women's pelvic health company, launched the Prospective On-Market Patient-reported Outcomes for Milli Vaginal Dilator trial. This study aims to evaluate the effectiveness of the Milli Vaginal Dilator in reducing discomfort associated with vaginismus by collecting patient-reported outcomes through a remote trial model.
In August 2024, Owen Mumford, a UK-based medical device solutions company, acquired Empelvic for an undisclosed amount. Through this acquisition, Owen Mumford seeks to strategically enhance its pelvic and sexual health portfolio by incorporating Empelvic's innovative technologies into its existing product range, which includes vaginal dilators and vacuum therapy devices. Empelvic is a Denmark-based company specializing in pelvic floor cushion technology and the manufacture of vaginal dilators.
Major companies operating in the vaginal dilators market are McKesson Corporation, Medline Industries LP , CooperSurgical Inc., MedGyn Products Inc., Femmax, CalExotics, GPC Medical Ltd., AvaCare Medical, Soul Source Inc., Panpac Medical Corporation, Velvi, Amielle, Intimate Rose, Hope&Her, Berman Center, NeuEve LLC, Dr. Berman's Dilators, Vuvatech Inc., Marina Medical Instruments Inc., Bien Aus Pty Ltd.
North America was the largest region in the vaginal dilators market in 2025. The regions covered in the vaginal dilators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the vaginal dilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The vaginal dilators market consists of sales of standard dilators, thermal dilators, and custom dilators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Vaginal Dilators Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses vaginal dilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for vaginal dilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vaginal dilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.